Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis, Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05451420
What this trial is testing

Inactive HBsAg Carriers (IHCs) Treated With Pegylated Interferon α2b Based Intervention Therapy

Who this might be right for
Chronic Hepatitis B
Henan Provincial People's Hospital 33
Testing effectiveness (Phase 2)Study completedNCT00166296
What this trial is testing

Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients

Who this might be right for
Major Depressive DisorderHepatitis C, Chronic
Germans Trias i Pujol Hospital 133
Testing effectiveness (Phase 2)Study completedNCT00475176
What this trial is testing

S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 24
Testing effectiveness (Phase 2)Study completedNCT00495391
What this trial is testing

Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C

Who this might be right for
Chronic Hepatitis C
Romark Laboratories L.C. 64
Not applicableStudy completedNCT01647191
What this trial is testing

Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China

Who this might be right for
Hepatitis C
Shanghai Mental Health Center 240
Not applicableStudy completedNCT02508090
What this trial is testing

Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin

Who this might be right for
Chronic Hepatitis C
Hoffmann-La Roche 10
Testing effectiveness (Phase 2)Study completedNCT00984620
What this trial is testing

Short Term Treatment With BI 201335, Peginterferon-alpha 2a and Ribavirin in Hepatitis c Virus Genotype-1 Treatment-naïve Patients (SILEN-C3)

Who this might be right for
Hepatitis C
Boehringer Ingelheim 160
Post-approval studies (Phase 4)Study completedNCT02609893
What this trial is testing

Pilot Treatment as Prevention for HCV Among Persons Who Actively Inject Drugs

Who this might be right for
Chronic Hepatitis C
Phillip Coffin, MD, MIA 31
Large-scale testing (Phase 3)Study completedNCT01498068
What this trial is testing

Open-Label, Bridging Study of Telaprevir in Treatment-Naïve and Treatment-Experienced Russian Patients With Genotype 1 Chronic Hepatitis C

Who this might be right for
Genotype 1 Chronic Hepatitis C
Janssen-Cilag International NV 36
Not applicableWithdrawnNCT00876174
What this trial is testing

Effects of Genotypes on Interferon Signaling in Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
University of Nebraska
Not applicableLooking for participantsNCT01280825
What this trial is testing

The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

Who this might be right for
Patients Undergoing Routine Health CareHeart DiseasesInflammatory Bowel Diseases+5 more
University of Chicago 1,200
Large-scale testing (Phase 3)Study completedNCT02607735
What this trial is testing

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previously Received Treatment With Direct-Acting Antiviral Therapy

Who this might be right for
Hepatitis C
Gilead Sciences 416
Testing effectiveness (Phase 2)Ended earlyNCT02738008
What this trial is testing

Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection

Who this might be right for
Hepatitis B
Arrowhead Pharmaceuticals 12
Testing effectiveness (Phase 2)Study completedNCT01749150
What this trial is testing

Ritonavir-Boosted Danoprevir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients of Asian Origin With Chronic Hepatitis C Genotype 1 With or Without Cirrhosis

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 61
Not applicableNot Yet RecruitingNCT07544121
What this trial is testing

Effect of Babao Dan Capsule Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis

Who this might be right for
HEPATITIS B CHRONICCirrhosis, LiverHepatocellular Carcinoma (HCC)
Nanfang Hospital, Southern Medical University 1,034
Testing effectiveness (Phase 2)Study completedNCT02161952
What this trial is testing

Pirfenidone, an Antifibrotic and Antiinflammatory Drug

Who this might be right for
FibrosisHepatitis C Chronic
University of Guadalajara 150
Not applicableLooking for participantsNCT04493385
What this trial is testing

The Hepatitis C Transplant Collaborative

Who this might be right for
Transplant; Failure, HeartHepatitis C
Baylor Research Institute 500
Post-approval studies (Phase 4)Study completedNCT01522625
What this trial is testing

Tenofovir in Chronic Hepatitis B With Mild ALT Elevation

Who this might be right for
Chronic Hepatitis B
E-DA Hospital 160
Not applicableUnknownNCT04103840
What this trial is testing

Invasive Fungal Infections in Severe Alcohol-associated Hepatitis

Who this might be right for
Severe Alcoholic HepatitisChronic Liver Disease and Cirrhosis
Post Graduate Institute of Medical Education and Research, Chandigarh 160
Not applicableStudy completedNCT03402334
What this trial is testing

Counseling Hepatitis C Virus (HCV) Positive Patients for Cardiovascular Disease Risk Factors

Who this might be right for
Hepatitis CAtherosclerosis
Tulane University 231
Next Page